DKK1 and myeloid sarcoma: To explore whether the Wnt pathway plays a role in the treatment effect of MS in TBI, we preinjected DKK-1 (a specific inhibitor of the Wnt pathway that can block the binding between Wnt proteins and cell membrane receptors) into the encephalocele of rats.